What CEFEA does

CEFEA (legal name: Cefea Sp. z o.o. Sp. k.) is a Warsaw-based pharmaceutical contract services organization operating under a multi-entity capital group structure (Grupa Kapitałowa CEFEA). The company provides integrated pharmaceutical services spanning contract manufacturing and repackaging of medicinal products, medical devices, and dietary supplements; full clinical trial supply support including IMP import, labeling, packaging, QP certification and release, comparator sourcing, and cold-chain logistics; parallel and non-EU import services including GMP inspection preparation and regulatory documentation; pharmaceutical wholesale distribution; regulatory consulting and GMP/GDP audits; and raw materials supply for cosmetic, food, and pharmaceutical industries.

Underlying technology is conventional but heavily regulated: validated temperature and humidity monitoring with controlled storage zones (+2°C to +8°C and +15°C to +25°C), serialization and 2D Data Matrix coding for traceability, specialized packaging lines capable of handling psychotropic substances (categories I-N through IV-P), and a Class A warehouse co-located near Warsaw's Chopin Airport and the A2 highway. CEFEA holds ISO 9001:2015, ISO 13485:2016, ISO 14001:2015, and ISO GDP certifications, alongside a pharmaceutical manufacturing and import authorization, a wholesale distribution permit (NZOH.5100.81.2022.MG.4), and parallel import authorization from the Chief Pharmaceutical Inspector.

The business model is sales-led, B2B, and quote-based, with no public pricing. Revenue streams include one-time contract manufacturing/repackaging fees, professional services for clinical trial support and consulting, managed services for non-EU import programs, and transaction-fee wholesale distribution. The firm employs approximately 20 people and serves enterprise pharmaceutical corporations, parallel import leaders, CROs, and non-EU (notably Far East) pharmaceutical manufacturers seeking EU market entry. Revenue is not publicly disclosed; the only external financing referenced is a 2020 non-dilutive working-capital subsidy from European Funds (Fundusze Europejskie) under agreement POIR.03.04.00-14-0809/20-00. No private equity, venture capital, or institutional ownership is disclosed.

Name

CEFEA

Legal name

Cefea Sp. z o.o. Sp. k.

Website

https://cefea.pl

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

CEFEA is a Warsaw-based pharmaceutical contract services firm providing repackaging, clinical trial supply, import, wholesale distribution, and regulatory consulting to enterprise pharma manufacturers, CROs, and non-EU pharma companies entering the EU market.

Ownership category

akta.pro rank

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Manufacturing and repackaging services: Contract manufacturing and repackaging of pharmaceutical products, medical devices, and dietary supplements. Includes serialization, labeling, and packaging services under manufacturing permits.
2. Clinical trial support services: Comprehensive clinical trial support including import of clinical trial products, labeling, packaging, QP certification, comparator sourcing, logistics, and disposal.
3. Import services: Import of pharmaceutical products for non-EU companies entering the EU market, including regulatory documentation, GMP inspection preparation, and EU release.
4. Pharmaceutical wholesale distribution: Distribution of pharmaceutical products, medical devices, and dietary supplements through pharmaceutical warehouse operations.
5. Consulting and advisory services: Regulatory consulting, GMP/GDP audits, registration documentation preparation, and strategic advisory services for pharmaceutical companies entering the EU market.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

CEFEA provides contract pharmaceutical services including repackaging of medicinal products, medical devices, and dietary supplements; full-service clinical trial support (IMP import, blinding, QP release, comparator sourcing, logistics, returns); import of medicinal products from non-EU countries into the European market; GDP-compliant wholesale distribution with temperature-controlled storage; and regulatory consulting/GMP-GDP audit services. Operations are conducted under pharmaceutical manufacturing and wholesale distribution permits from a Warsaw facility.

Product overview

CEFEA operates as a contract pharmaceutical services organization offering an integrated portfolio of services. The core offerings include drug repackaging and contract manufacturing (Przepakowywanie leków), clinical trial support services (Obsługa Badań Klinicznych), and medicinal product import for non-EU companies. These are supported by pharmaceutical wholesale (Hurtownia farmaceutyczna), raw materials supply (Surowce), and consulting services (Usługi doradcze). The services are designed to work together—imported products flow through their warehouse, repackaging enables market adaptation, clinical trial services support product development, and consulting facilitates market entry for non-EU manufacturers.

Differentiator

Problem solved

Functional benefit

Products and services

• Przepakowywanie leków (Drug Repackaging) Contract manufacturing and repackaging of medicinal products, medical devices, and dietary supplements. Services include primary and secondary packaging, labeling, language version changes, promotional packaging, serialization, and 2D Data Matrix coding, performed under pharmaceutical manufacturing authorization covering psychotropic substances.
• Obsługa Badań Klinicznych (Clinical Trial Support) Comprehensive clinical trial support services for Sponsors and CROs, including IMP import, labeling and packaging, blinding, comparator sourcing, Qualified Person (QP) certification and batch release, validated cold-chain logistics (+2°C to +8°C and +15°C to +25°C), returns, and waste disposal.
• Import produktów leczniczych (Medicinal Product Import) Import services for medicinal products from non-EU countries into the European market. Covers parallel import authorization, regulatory documentation preparation, GMP inspection support, batch release by Qualified Person, and full logistics through the Warsaw warehouse.
• Hurtownia farmaceutyczna (Pharmaceutical Wholesale) Wholesale distribution of medicinal products, medical devices, and dietary supplements with GDP-compliant storage in two temperature ranges (+2°C to +8°C and +15°C to +25°C) and qualified transport monitoring from a Class A Warsaw warehouse.
• Usługi doradcze (Consulting, Audits, Strategies) Regulatory consulting services for non-EU pharmaceutical companies seeking to enter the Polish/European market, including legal foundation creation, registration documentation, GMP inspection preparation, and distribution logistics strategy. Also covers GMP/GDP audits.
• Surowce (Raw Materials) Supply of high-quality raw materials for cosmetic, food, and pharmaceutical industries and for pharmacy compounding, distributed through the Warsaw facility.

Quantifiable outcome

• Validated cold chain storage capacity in two temperature ranges: +2°C to +8°C and +15°C to +25°C
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• NextPharma: European CDMO focused on contract manufacturing, packaging, and serialization for pharmaceutical and healthcare products. Comparable to CEFEA in offering mid-scale GMP-compliant packaging, labeling, and distribution services to pharma clients across Europe.
• Recipharm: Swedish-headquartered CDMO providing contract manufacturing, serialization, and pharmaceutical development services across Europe. Comparable to CEFEA as a European specialist offering GMP-compliant manufacturing and packaging for pharma clients, though with broader capabilities and more sites.
• Central Pharma: UK-based pharmaceutical contract service provider offering contract packing, relabeling, and clinical trial supply. Comparable to CEFEA as a mid-sized European specialist in repackaging, labeling, and clinical trial logistics for pharma clients.

Broad incumbents

• Catalent: Global CDMO offering contract manufacturing, packaging, and clinical supply services to pharmaceutical companies. Directly comparable as a much larger incumbent serving the same pharma customer base across repackaging, serialization, and clinical trial supply, but at significantly greater scale and geographic breadth than CEFEA.
• Eurofins CDMO: European contract development and manufacturing organization providing pharmaceutical development, manufacturing, and packaging services. Comparable to CEFEA in providing EU GMP/GDP-compliant contract services to pharma clients across formulation, manufacturing, and distribution.
• Aenova Group: European pharmaceutical contract manufacturer offering solid dosage forms, sterile and packaging services. Comparable to CEFEA in offering EU GMP-compliant contract manufacturing and packaging, but operating at much larger scale across multiple European sites.
• Vetter Pharma: German-based contract manufacturer specializing in aseptic fill-finish and packaging of injectable pharmaceuticals. Comparable to CEFEA in offering EU-compliant contract manufacturing and packaging, though focused on injectables and operating at significantly larger scale.

Regional players

• Polpharma Biologics: Polish pharmaceutical manufacturer and contract services provider based in Poland. Comparable to CEFEA as a Poland-based pharma services company serving EU and international clients, though with manufacturing rather than repackaging as its core focus.
• Temmler Pharma: German-based pharmaceutical contract manufacturer and packager serving European pharma clients. Comparable to CEFEA in offering EU GMP-compliant contract manufacturing, repackaging, and serialization, though operating primarily in Germany rather than Poland.

Emerging players

• AdvaCare Pharma: Pharmaceutical company with contract manufacturing and distribution capabilities across multiple regulated and emerging markets. Comparable to CEFEA in offering contract manufacturing, serialization, and global distribution services, though focused on generics and emerging markets rather than EU repackaging.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cefea

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CEFEA